Advancing Cancer Research: Insights and Innovations in Pathogenesis and Targeted Therapies

por Wu, Yong, Vadgama, Jaydutt V.
Publicado 2023

Basal-like breast cancer with low TGFβ and high TNFα pathway activity is rich in activated memory CD4 T cells and has a good prognosis

por Liu, Dingxie, Vadgama, Jaydutt, Wu, Yong
Publicado 2021

Constitutive Activation of STAT3 Signaling Regulates hTERT and Promotes Stem Cell-Like Traits in Human Breast Cancer Cells

por Chung, Seyung S., Aroh, Clement, Vadgama, Jaydutt V.
Publicado 2013

Epithelial-Mesenchymal Transition and Breast Cancer

por Wu, Yanyuan, Sarkissyan, Marianna, Vadgama, Jaydutt V.
Publicado 2016

CCL2/CCR2 signaling in cancer pathogenesis

por Hao, Qiongyu, Vadgama, Jaydutt V., Wang, Piwen
Publicado 2020

PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers

por Keung, Man Yee T., Wu, Yanyuan, Vadgama, Jaydutt V.
Publicado 2019

Wild-Type TP53 Predicts Poor Prognosis in Patients with Gastric Cancer

por Deng, Wenhong, Hao, Qiongyu, Vadgama, Jaydutt, Wu, Yong
Publicado 2021

Triple Negative Breast Tumors in African-American and Hispanic/Latina Women Are High in CD44+, Low in CD24+, and Have Loss of PTEN

por Wu, Yanyuan, Sarkissyan, Marianna, Elshimali, Yahya, Vadgama, Jaydutt V.
Publicado 2013

STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits

por CHUNG, SEYUNG S., GIEHL, NOLAN, WU, YANYUAN, VADGAMA, JAYDUTT V.
Publicado 2013

Combination treatment with flavonoid morin and telomerase inhibitor MST-312 reduces cancer stem cell traits by targeting STAT3 and telomerase

por Chung, Seyung S., Oliva, Bryant, Dwabe, Sami, Vadgama, Jaydutt V.
Publicado 2016

GROα overexpression drives cell migration and invasion in triple negative breast cancer cells

por Bhat, Kruttika, Sarkissyan, Marianna, Wu, Yanyuan, Vadgama, Jaydutt V.
Publicado 2017

Phytochemicals in Inhibition of Prostate Cancer: Evidence from Molecular Mechanisms Studies

por Hao, Qiongyu, Wu, Yanyuan, Vadgama, Jaydutt V., Wang, Piwen
Publicado 2022

From Interaction to Intervention: How Mesenchymal Stem Cells Affect and Target Triple-Negative Breast Cancer

por Wu, Yong, Shum, Hang Chee Erin, Wu, Ke, Vadgama, Jaydutt
Publicado 2023

Response of Breast Cancer Cells to PARP Inhibitors Is Independent of BRCA Status

por Keung, Man Yee, Wu, Yanyuan, Badar, Francesca, Vadgama, Jaydutt V.
Publicado 2020

Genetic variants in African-American and Hispanic patients with breast cancer

por Dutta, Pranabananda, Keung, Man Y., Wu, Yanyuan, Vadgama, Jaydutt V.
Publicado 2022

Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer

por Shum, Hang Chee Erin, Wu, Ke, Vadgama, Jaydutt, Wu, Yong
Publicado 2023

Activation of Akt1 accelerates carcinogen-induced tumorigenesis in mammary gland of virgin and post-lactating transgenic mice

por Wu, Yanyuan, Kim, Juri, Elshimali, Yayha, Sarkissyan, Marianna, Vadgama, Jaydutt V
Publicado 2014

Association of Vitamin D3 Level with Breast Cancer Risk and Prognosis in African-American and Hispanic Women

por Wu, Yanyuan, Sarkissyan, Marianna, Clayton, Sheilah, Chlebowski, Rowan, Vadgama, Jaydutt V.
Publicado 2017

MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis

por Dutta, Pranabananda, Sarkissyan, Marianna, Paico, Kimberly, Wu, Yanyuan, Vadgama, Jaydutt V.
Publicado 2018

Celecoxib in breast cancer prevention and therapy

por Li, Jieqing, Hao, Qiongyu, Cao, Wei, Vadgama, Jaydutt V, Wu, Yong
Publicado 2018